Portfolio News
- October 07, 2008 Vodafone Germany Uses KXEN
- October 06, 2008 Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
- October 02, 2008 Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
- October 02, 2008 Crocus Technology Raises 11.5M Euros to Develop MRAM Technology - French Development Agency Also Awards 3M Euros Funding
Contact
Contact information for our offices in San Francisco, Menlo Park, and San Diego.
For information about our sister firm Sofinnova Partners based in Paris, France, please visit www.sofinnova.fr.